Paratek Pharmaceuticals, Inc. - stock earnings
Stock symbol PRTK is outdated, potentially delisted? Maybe it is available on other exchange?
PRTK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -14.6 million USD | 40.0 million USD |
| 2022Q4 | -7.2 million USD | 75.6 million USD |
| 2022Q3 | -20.9 million USD | 30.2 million USD |
| 2022Q2 | -17.6 million USD | 29.6 million USD |
| 2022Q1 | -17.9 million USD | 24.9 million USD |
| 2021Q4 | -32.3 million USD | 31.8 million USD |
| 2021Q3 | -18.2 million USD | 24.4 million USD |
| 2021Q2 | 9.7 million USD | 57.5 million USD |
| 2021Q1 | -18.3 million USD | 16.4 million USD |
| 2020Q4 | -25.0 million USD | 16.0 million USD |
PRTK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -63.6 million USD | 160.3 million USD |
| 2021 | -59.1 million USD | 130.2 million USD |
| 2020 | -96.5 million USD | 46.9 million USD |
| 2019 | -128.8 million USD | 16.5 million USD |
| 2018 | -112.4 million USD | 17.1 million USD |
| 2017 | -89.1 million USD | 12.6 million USD |
PRTK
Price: $2.23
52 week price:
Earnings Per Share: 0.02 USD
P/E Ratio: -4.84
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 205400
Ebitda: -19.6 millionMarket Capitalization: 106.0 million